Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.9% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment reporting

Analytics

N/A
1(50.0%)
Early Phase 1
1(50.0%)
2Total
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03968237Withdrawn

Measures to Improve Outcomes After an Opioid Overdose

Role: lead

NCT03120468Early Phase 1Completed

Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

Role: lead

NCT03969251Not ApplicableCompleted

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder

Role: lead

All 3 trials loaded